Agranulocytosis and neutropenia with typical and atypical neuroleptics [2]

American Journal of Psychiatry

Volumn 158, Issue 10, 2001, Pages 1736-1737

  Hong, X ^a   Wang, X ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; GRANULOCYTE COLONY STIMULATING FACTOR; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; RISPERIDONE;

ADULT; AGRANULOCYTOSIS; BONE MARROW BIOPSY; CASE REPORT; DRUG SAFETY; FEMALE; HUMAN; LETTER; LEUKOCYTE COUNT; NEUTROPENIA; NEUTROPHIL; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; AGRANULOCYTOSIS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CLOZAPINE; FEMALE; HUMANS; LEUKOCYTE COUNT; NEUTROPENIA; PERPHENAZINE; PIRENZEPINE; RISPERIDONE; SCHIZOPHRENIA;

EID: 0034808825     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.158.10.1736     Document Type: Letter

References (3)

1. Olanzapine-induced agranulocytosis
2. Risperidone-associated agranulocytosis
3. Genetic determinants of drug-induced agranulocytosis: Potential risk of olanzapine?